Kos, M. Et Al. 2016. Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer. Wiener Klinische Wochenschrift , vol.128, no.17-18 , 635-640.

Kos, M., Hocazade, C., Kos, F. T., Uncu, D., Karakas, E., Dogan, M., ... Uncu, H. G.(2016). Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer. Wiener Klinische Wochenschrift , vol.128, no.17-18, 635-640.

Kos, Mehmet Et Al. "Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer," Wiener Klinische Wochenschrift , vol.128, no.17-18, 635-640, 2016

Kos, Mehmet Et Al. "Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer." Wiener Klinische Wochenschrift , vol.128, no.17-18, pp.635-640, 2016

Kos, M. Et Al. (2016) . "Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer." Wiener Klinische Wochenschrift , vol.128, no.17-18, pp.635-640.

@article{article, author={Mehmet Kos Et Al. }, title={Prognostic role of pretreatment platelet/lymphocyte ratio in patients with non-small cell lung cancer}, journal={Wiener Klinische Wochenschrift}, year=2016, pages={635-640} }